Myasthenia gravis remission and anti-AChR ab reduction after immunosuppressive and anti-neoplastic therapy in a patient with thymic Hodgkin's disease.
Ferrò
M T
MT
Riccardi
T
T
Montanelli
A
A
Bernasconi
P
P
Mantegazza
R
R
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001323:Autoantibodies / Q000378:metabolism; D005260:Female; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000276:immunology*; D011950:Receptors, Cholinergic / Q000276:immunology*; D013934:Thymectomy / Q000379:methods
D000970:Antineoplastic Agents; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D011950:Receptors, Cholinergic